MedPath

Sodium Polystyrene Sulfonate

SODIUM POLYSTYRENE SULFONATE, USP

Approved
Approval ID

e148d6d4-5abc-47c0-a365-8a14d03597a5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 25, 2019

Manufacturers
FDA

ATLANTIC BIOLOGICALS CORP

DUNS: 047437707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Polystyrene Sulfonate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17856-1136
Application NumberANDA040905
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateSeptember 24, 2019
FDA Product Classification

INGREDIENTS (1)

SODIUM POLYSTYRENE SULFONATEActive
Quantity: 1 g in 1 g
Code: 1699G8679Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Polystyrene Sulfonate - FDA Drug Approval Details